Hi there, it's Matt here and a warm welcome back to the podcast and back to another of our

general brain science episodes. This is a topic a number of you asked for after I did a social

media post about a certain class of medications for sleep apnea, specifically the GLP ones.

Let's take a step back.

Because there is sometimes a moment in science when a familiar character steps on stage

wearing an unfamiliar costume.

We start wondering if we ever understood the character at all.

GLP ones are having that moment.

If you follow health news, you know GLPs like OZMPIC from the metabolic world.

It helped drive the rise of the blockbuster GLP agonists used for weight regulation.

For years, researchers viewed GLPs as a gut hormone that told the pancreas

how to behave, told the stomach how fast to empty, and told the brain when enough food

had been eaten. And that was the story, full stop. Except it was not the full story. A new review

just published that I found fascinating released in the

International Journal of Molecular Sciences did something meaningful. It gathered an enormous

amount of scattered evidence about GLPs and placed that evidence in a single frame. When you

step back and look at that frame, they suggested

you see something interesting. GLPs are no longer tied down to the metabolic plot. Instead,

some scientists think they also look like potential defenders of the human brain. This episode is that story evaluated critically,

a story about a molecule with a side career that no one expected, a story about how the gut

can influence the fate of brain cells, a story that might change the way we think about aging, memory, disease,

and the future of neurodegeneration research. So let us start with where GLPs come from,

...